Impulse Control Genes Linked to Addiction Risk, Rutgers Study Finds

Most of the genetic risk for developing a substance use disorder stems from genes influencing brain processes related to reward, impulse regulation, and consequence assessment – rather than genes directly tied to substance use itself. A recent study led by researchers at Rutgers Health sheds light on these complex genetic underpinnings of addiction.

Genetic Pathways to Addiction

Researchers, headed by Holly Poore, a faculty instructor of psychiatry at Rutgers Robert Wood Johnson Medical School, analyzed genetic data from over 2.2 million individuals through genome-wide association studies. The findings, published in Nature Mental Health, reveal that genetic risk operates through two primary pathways:

• Behavioral Disinhibition: This pathway, also known as an “externalizing” pathway, involves brain systems responsible for reward processing, self-control, and risk-taking. It’s characterized by difficulty regulating impulses and includes conditions like ADHD, conduct problems, and impulsivity. This pathway is common across various forms of addiction and related behavioral issues.
• Substance-Specific Pathways: These pathways are more narrowly linked to particular drugs, such as genes involved in alcohol metabolism or nicotine receptors.

Shared Genetic Roots

“Most of the genetic predisposition to substance use disorders isn’t about how bodies respond to drugs; it’s about how brains are wired,” explains Danielle Dick, director of the Rutgers Addiction Research Center within the Rutgers Brain Health Institute and senior author of the study. “Those same genes show up across many outcomes – things like ADHD, conduct problems and other risky behaviors – and then layered on top of that are genes that are more specific to each substance.”

The research team analyzed data related to alcohol, tobacco, cannabis, and opioid use disorders, alongside externalizing traits like ADHD and risk-taking behavior. This approach allowed them to identify hundreds of genetic variants associated with broad externalizing liability and genes specific to certain substances.

Modeling Addiction and Related Traits

By modeling addiction alongside these related traits, researchers were able to more effectively detect genetic effects without losing the ability to identify substance-specific signals. Genes linked to the broad liability were found to be involved in brain signaling, reward processing, and neural plasticity, although substance-specific genes mapped to pathways like alcohol metabolism or nicotinic acetylcholine receptors.

“Traditionally, gene-finding efforts have focused on one disorder at a time,” says Poore. “But substance use disorders almost never occur in isolation, and decades of twin and family studies have shown that they share a lot of their genetic roots with each other and with other externalizing conditions. By modeling that shared genetic architecture directly, we were able to discover more about both the broad and specific biological pathways that contribute to addiction.”

Polygenic Scores and Future Implications

The researchers also developed polygenic scores – combining thousands of genetic variants into a single index of genetic liability. Broad externalizing polygenic scores were effective in predicting risk for multiple substance use disorders, while substance-specific scores offered more precise information about vulnerability to specific drugs.

“From a translational perspective, we can start to suppose about genetic risk on two levels,” Dick adds. “A broader metric can share us who is generally more vulnerable to addiction and other externalizing problems, while more specific scores can help us understand who is at higher risk for problems with different substances. That doesn’t mean genes determine someone’s destiny, but they can help us identify who might benefit most from targeted prevention or earlier intervention.”

The study’s analyses also pointed to potential biological systems and medications that could be repurposed for treatment. Many of the identified genes overlapped with those implicated in other psychiatric and substance-related disorders, highlighting the shared biology across these conditions.

Limitations and Future Research

The authors acknowledge that their analyses were limited to individuals of European ancestry, emphasizing the need for more diverse genomic research to ensure findings are equitable across populations.

“Addiction is incredibly complex, and this study shows just how important it is to gaze beyond any single substance or single gene,” Poore concludes. “By understanding the common genetic roots that link substance use disorders with other forms of behavioral disinhibition – as well as the pathways that are specific to alcohol, nicotine, cannabis or opioids – we can build a more complete picture of vulnerability and ultimately support better prevention, intervention and treatment strategies.”